Three sets of primers were designed for PCR detection and differentiation of Campylobacter jejuni and Campylobacter coli. The first PCR assay was designed to coidentify C. jejuni and C. coli based on their 16S rRNA gene sequences. The second PCR assay, based on the hippuricase gene sequence, identified all tested reference strains of C. jejuni and also strains of that species which lack detectable hippuricase activity. The third PCR assay, based on the sequence of a cloned (putative) aspartokinase gene and the downstream open reading frame, identified all tested reference strains of C. coli. The assays will find immediate application in the rapid identification to species level of isolates. The assays combine with a protocol for purification of total DNA from fecal samples to allow reproducible PCR identification of campylobacters directly from stools. Of 20 clinical samples from which campylobacters had been cultured, we detected C. jejuni in 17, C. coli in 2, and coinfection of C. jejuni and Campylobacter hyointestinalis in 1. These results were concordant with culture and phenotypic identification to species level. Strain typing by PCR-restriction fragment length polymorphism of the flagellin (flaA) gene detected identical flaA types in fecal DNA and the corresponding campylobacter isolate. Twenty-five Campylobacter-negative stool samples gave no reaction with the PCR assays. These PCR assays can rapidly define the occurrence, species incidence, and flaA genotypes of enteropathogenic campylobacters.
The following five anaerobic species were tested following incubation on 5% Columbia blood agar plates at 37°C in an anaerobic work station (Don Whitley Scientific, Ltd.) which maintained an atmosphere of 5% CO 2 (16) .
PCR primer design and amplification. Regions of the 16S rRNA (rrs) gene sequence which were identical for C. jejuni, C. coli, and a recently described (porcine) species, C. hyoilei, but different for other Campylobacter species, were sought. For the first PCR, a primer pair was designed from such a region with mismatches located at the 3Ј end of the primer-template duplex. The second PCR primer pair was based on the sequence of the hippuricase gene (11) , and the third was based on the sequence of a C. coli genomic clone (see below). The software used was Primerselect (Lasergene DNAstar package).
All PCR amplifications were performed in a solution containing 20 mM TrisHCl (pH 8.3); 50 mM KCl; 2.5 mM MgCl 2 ; 200 M (each) dATP, dCTP, dGTP, and dTTP; 0.4 M each primer; 0.025 U of Taq DNA polymerase (Life Technologies, Ltd.)/l; and 1 ng of genomic DNA/l. Reaction mixes were overlaid with mineral oil and subjected to 25 cycles of amplification in a DNA thermal cycler (Stratagene Robocycler). The cycling was as follows: denaturation at 94°C for 1 min, annealing at a temperature specific to the primer pair (see below) for 1 min, and extension at 72°C for 1 min. For C. jejuni-C. coli PCR, an annealing temperature of 58°C was used; for hippuricase gene PCR, an annealing temperature of 66°C was used; and for C. coli-specific PCR, an annealing temperature of 60°C was used. PCRs specific for C. lari, C. upsaliensis, C. helveticus, C. fetus, and C. hyointestinalis were performed as previously described (14) . Oligonucleotide primers were purchased from Cruachem U.K., Ltd. PCR amplicons (5-l aliquots) were electrophoresed in 1% agarose (Sigma Type II, medium EEO) gels, stained with ethidium bromide, and photographed under UV light.
Cloning, slot blot hybridization, and sequencing of genomic DNA fragments from C. coli NCTC 11366 T . Genomic DNA was prepared as described above from C. coli NCTC 11366
T and digested with HindIII. The resultant fragments were separated in a preparative agarose gel. DNA from a gel slice containing fragments between 0.5 and 4 kbp was subjected to purification with Geneclean (Bio 101, Inc.) and ligated into cloning vector pUC19. Following transformation into E. coli XL1 Blue cells (Stratagene), recombinant colonies were detected by standard methods (19) . Cloned fragments were amplified from suspensions of recombinant XL1 Blue cells with primers designed to anneal at either side of the multiple cloning site. The forward primer was 5Ј-GCT ATG ACC ATG ATT ACG C-3Ј, and the reverse primer was 5Ј-TTG TAA AAC GAC GGC CAG T-3Ј. These primers were also used to sequence suitable candidate clones according to the manufacturer's instructions for the Perkin-Elmer dye terminator cycle sequencing kit.
Slot blot hybridization experiments with total genomic DNA of Campylobacter type strains were performed by using PCR-amplified cloned DNAs as probes, as previously described (13) .
Fecal samples and campylobacter isolates. Fecal samples from 25 gastroenteritis patients were provided by Tooting Public Health Laboratory, London, United Kingdom. No Salmonella spp., Shigella spp., or Campylobacter spp. had been isolated from 5 of these samples, while Campylobacter spp. had been isolated from 20 of them, by culture on modified charcoal cefoperazone deoxycholate agar (32 mg of cefoperazone liter Ϫ1 ), incubated microaerobically at 37°C for 48 h. These 20 isolates were also provided and were identified biochemically by us to the species level by the following procedures: Gram stain, oxidase and catalase activities, hippurate hydrolysis, indoxyl acetate hydrolysis, hydrogen sulfide production from triple sugar iron agar, and susceptibility to nalidixic acid and cephalothin (24) . Fecal samples were also provided by 20 healthy volunteers. All fecal samples were tested with the range of PCR primers described in this study and reference 14.
Nucleic acid isolation from bacterial cultures and from feces. Genomic DNA was extracted from 24-to 48-h blood agar plate cultures according to the method of Wilson (28) and resuspended in TE buffer (1ϫ TE is 10 mM Tris HCl plus 1 mM EDTA [pH 8.0]). Nucleic acid concentrations were measured spectrophotometrically and diluted in TE to a concentration of 10 ng/l.
Nucleic acids were extracted from fecal material by a modification of the procedure of Boom et al. (5) , by the addition of 150 l of 10% polyvinylpyrrolidone to the resuspended final product in 50 l of TE. The mixture was incubated at ambient temperature for 10 min, and the DNA was recovered by isopropanol precipitation.
Flagellin gene fingerprinting by PCR. The flagellin gene (flaA) was amplified according to the method of Alm and coworkers (2) by PCR directly from DNA extracted from fecal samples, as well as from the campylobacter strains isolated from the same material. In order to optimize the PCR for application to the DNA extracted from fecal material, the forward primer, pg50 (17) , was modified by the addition of 2 bases at the 3Ј end to 5Ј-ATG GCA TTT CGT ATT ACC AC-3Ј while the reverse primer, RAA19 (2) [5Ј-GCA CC(C/T) TTA AG(A/T) GT(A/G) GTT ACA-3Ј], was unmodified. PCR was performed as described above except that 30 cycles were employed, each consisting of 1 min at 94°C, 1 min at 60°C, and 1 min at 74°C. The resulting amplicons (approximately 1.5 kbp) were double digested with PstI and EcoRI (2, 20) . Fragments were analyzed on 3% NuSieve agarose gels (FMC Bioproducts).
Nucleotide sequence accession numbers. The sequences of both strands of CCCH and of the PCR amplicon from C. hyoilei have been deposited in GenBank under accession no. AF 017758 and AF 017759, respectively.
RESULTS
The 16S rDNA-based PCR assay specific for C. jejuni and C. coli. Regions were identified from an alignment of 16S rRNA (rrs) gene sequences in which the sequences for C. jejuni and C. coli differed from those of all other Campylobacter species. From two such regions, nucleotides 609 to 629 and 1442 to 1469 (according to the E. coli numbering scheme), a primer pair was designed for coidentification of the two species. The sequence of the forward primer, termed CCCJ609F, was 5Ј-AAT CTA ATG GCT TAA CCA TTA-3Ј, and the sequence of the reverse primer, termed CCCJ1442R, was 5Ј-GTA ACT AGT TTA GTA TTC CGG-3Ј. This assay was tested against the DNAs of the type strains of all species in the genus Campylobacter. The primer pair was employed in a PCR with an annealing temperature of 58°C, generating an amplicon of 854 bp from all tested strains of both C. jejuni subspecies and C. coli but not from all tested strains of the other Campylobacter species with the exception of C. hyoilei, a recently described species associated with proliferative enteritis of pigs (1) . This species is a close phylogenetic relative of C. jejuni and C. coli (see below). There was no reaction with any other noncampylobacter species listed in Materials and Methods.
The hippuricase gene-based PCR assay specific for C. jejuni. The gene encoding hippuricase (hip) was recently cloned from C. jejuni, and a DNA probe derived from it hybridized to genomic DNAs of all strains of C. jejuni, including 11 phenotypically hippuricase-negative strains (11) . On the basis of the nucleotide sequence (11), we designed a primer pair for amplification of the hip gene, which is absent from campylobacters other than C. jejuni. A forward primer, termed HIP400F, whose sequence was 5Ј-GAA GAG GGT TTG GGT GGT G-3Ј, was designed to anneal to nucleotides 400 to 418 of the hip sequence. A reverse primer, termed HIP1134R, whose sequence was 5Ј-AGC TAG CTT CGC ATA ATA ACT TG-3Ј, was designed to anneal to nucleotides 1112 to 1134. The predicted product size was 735 bp. By using a PCR cycle with an annealing temperature of 66°C, an amplicon of this size was generated from all tested strains of C. jejuni subsp. jejuni and subsp. doylei, irrespective of their hippuricase phenotypes. No product was obtained from any tested strains of C. coli or from any strain of any other Campylobacter species, including C. hyoilei. No product was obtained from any other enteric bacteria tested (see above).
The PCR assay identifying C. coli. Genomic DNA from the type strain of C. coli was digested with HindIII, and those fragments sized between 0.5 and 4.0 kbp were cloned into plasmid pUC19. Twenty such cloned fragments, amplified by PCR from cultures of E. coli containing recombinant plasmids (see Materials and Methods), were hybridized against genomic DNA from the type strains of C. coli, C. jejuni, and C. hyoilei. A probe that hybridized only to the type strain of C. coli failed to hybridize to other serotype reference strains of that species. A clone (termed CCCH) that hybridized to all C. coli Penner serotype reference strains, but not to those of C. jejuni, crossreacted with the type strain of C. hyoilei.
Both strands of CCCH were sequenced. The 583 bp of DNA cloned from C. coli NCTC 11366
T encoded an open reading frame of 405 bp (135 amino acids) immediately downstream of 178 bp of sequence with homology to the 3Ј end of aspartokinase genes. Primers were designed based on the sequence of this clone. The forward primer, termed CC18F, was located between nucleotides 18 and 38, and the reverse primer, termed CC519R, was located between nucleotides 499 and 519. The primer sequences were 5Ј-GGT ATG ATT TCT ACA AAG CGA G-3Ј for CC18F and 5Ј-ATA AAA GAC TAT CGT CGC GTG-3Ј for CC519R. By using a PCR cycle with an annealing temperature of 60°C, an amplicon of 500 bp was generated from all tested strains of C. coli and from C. hyoilei, but not from strains of other Campylobacter species, including those tested of C. jejuni, and not from any other tested bacterial enteropathogens (see above). The corresponding PCR amplicon from C. hyoilei was sequenced. By comparison with the C. coli sequence, there was a single nucleotide substitution at nucleotide 407.
Application to fecal samples. The clinical samples provided by the Tooting Public Health Laboratory had been stored at 4°C for at least 7 days. From 20 of them, Campylobacter spp. had been isolated (Table 1) , while from five others, no bacterial pathogens had been isolated (Table 1) . Of the 20 isolates, 18 were identified phenotypically by us as C. jejuni, and 2 were identified as C. coli.
Following extraction of fecal DNA, these 25 samples were screened by PCR with the primer pairs specific for C. jejuni, for C. coli, and for C. jejuni and C. coli together. The 16S rRNA gene-based PCR (for C. jejuni and C. coli together) was positive for the 20 fecal samples from which a campylobacter strain had been isolated (Fig. 1A) . For 18 of these 20 samples, the C. jejuni-specific PCR assay was also positive (Fig. 1B) while the C. coli-specific PCR was negative (Fig. 1C) . For two samples (Fig. 1, lanes 9 and 14) , the C. coli-specific PCR was positive (Fig. 1C) while the C. jejuni-specific PCR was negative (Fig.  1B) . The five samples from which no bacterial pathogens had been isolated (Fig. 1) gave a negative result for all three PCR assays. The results of the PCR assays were in complete agreement with phenotypic methods for identification of the bacterial isolates to the species level. The 20 C. jejuni and C. coli isolates were then genotyped by PCR-restriction fragment length polymorphism (RFLP) of the flaA gene. The flaA gene fragments were as shown in Fig. 2A . When the same experiment was performed with fecal DNA as the substrate, identical flaA fingerprints were obtained for matching fecal samples (Fig. 2B) and isolates (Fig. 2A) . The flaA fingerprints of the two C. coli isolates (Fig. 2A, lanes 9 and 14) matched those of a previously reported C. coli flaA fingerprint, designated fVI (20) .
The 25 samples were PCR screened with primers specific for C. lari, C. upsaliensis, C. helveticus, C. fetus, and C. hyointestinalis (14) . All samples but one were negative in these assays. Sample 6, from which C. jejuni had been isolated and detected by PCR, also gave an amplicon with primers which identify C. hyointestinalis. The primary culture from the corresponding fecal sample was reincubated at 25°C (conditions generally selective for C. hyointestinalis), and a small number of colonies were isolated. The pure culture which grew from these colonies was H 2 S positive in triple sugar iron agar stabs, hippurate negative, resistant to nalidixic acid, sensitive to cephalothin, and unable to hydrolyze indoxyl acetate, and it grew at both 25 and 42°C. These phenotypes differentiate C. hyointestinalis from C. jejuni. The isolate gave the appropriate PCR amplicon with primers specific for C. hyointestinalis. Twenty further fecal samples provided by healthy volunteers were screened with the whole range of PCR primers as described above, and all were found to be negative.
DISCUSSION
PCR assays described in this report were designed for rapid and definitive identification to the species level of C. jejuni and C. coli. A major application is the detection and identification to the species level of Campylobacter in diarrheic stools. In current laboratory practice, identification of campylobacters to the species level relies on relatively few phenotypic tests. For example, C. jejuni and C. coli are distinguished only by hippurate hydrolysis, while C. coli and C. upsaliensis are distinguished by the weak catalase activity and sensitivity to cephalothin of the latter species. Due to these limitations, clinical laboratories often report these enteropathogens simply as Campylobacter species. Even when a rapid hippurate hydrolysis phenotypic test is performed to identify C. jejuni isolates, significant difficulty remains in the identification of any hippurate-negative isolates, which could belong to other Campylobacter species or could indeed be hippurate-negative strains of C. jejuni (16) . Other methods, which are definitive, reliable, and easy to use, are required to facilitate rapid identification of campylobacters to the species level.
PCR is such an alternative. PCR assays which coidentify C. jejuni and C. coli, based on the 16S rRNA gene sequence (9, 23) , the flagellin (fla) gene sequence (17, 25) , and an intergenic region of the tandemly arranged flagellin genes (26) , have been previously reported, and PCR assays specific for C. jejuni, based on the 23S rRNA gene sequence (7) or that of a gene (mapA) coding for an outer membrane protein (21) , have also been reported. The fla gene-based assays (17, 25) have been successfully applied to fecal material, but it should be noted that, unlike the assays reported in the present study, they do not offer a primary distinction between C. jejuni and C. coli.
In this study we have designed and evaluated three new PCR assays which can be employed in several ways. The first of these (based on 16S rDNA) provides for coidentification (from a pure culture or from fecal material) of the major human enteropathogens C. jejuni and C. coli. By current isolation and culture methods, they are estimated to cause approximately 99% of campylobacter infections in England and Wales or the United States (3, 22) , and this assay can therefore match current reporting procedures for most clinical laboratories. Clearer understanding of the relative disease significance of campylobacters requires reliable identification to the species level. This is an important first step in epidemiological studies of campylobacter infection of humans. To this end, we have designed and evaluated PCR assays specific for C. jejuni and for C. coli. The respective PCR targets are unique to strains of C. jejuni (hippuricase gene) and to strains of C. coli or C. hyoilei (partial clone of the aspartokinase gene of C. coli), as is shown here in tests on a range of strains broadly representative of the species as measured by serotype diversity (48 Penner serotype reference strains of C. jejuni, 11 hippurate-negative strains of C. jejuni, 10 strains of C. jejuni subsp. doylei, and 14 Penner serotype reference strains of C. coli). The fact that the rrs and aspartokinase PCRs cross-react with C. hyoilei should be noted but is not likely to provide an obstacle to practical application, since this is a species which has not been isolated from humans.
Negative PCR results were obtained from all control bacterial strains tested; these included a wide range of non-jejuni, non-coli campylobacters, related genera, and unrelated enteric species. Twenty-five control stool samples (20 from healthy individuals and 5 from diarrheic patients) which were negative by culture for campylobacters were also PCR negative by the new assays. These samples would have contained a complete range of bacterial species native to the human gastrointestinal tract, as undefined fecal flora. This demonstrates the species specificity of the assays. Cultivable bacteria represent only a proportion of the total flora native to the gastrointestinal tract (4), and campylobacter culture-negative feces thus represent a comprehensive specificity control for these PCR assays.
With respect to the application of the PCR assays to fecal samples, we note that they avoid the necessity for culture and for subsequent multiple phenotypic tests. The relative frequency of C. jejuni (18 per 20 clinical samples) and C. coli (2 per 20 fecal samples) in this study is in agreement with previous prevalence data (3, 22) . We note that laboratory identification of C. coli is problematical since the species can be distinguished from C. jejuni only by the absence of hippurate hydrolysis. Since there is no positive phenotypic test specific for C. coli, we used flaA gene fingerprinting to substantiate the standard identification and to further validate our C. colispecific PCR.
Even in this limited sample, C. hyointestinalis was identified by PCR and an isolate could be retrospectively cultured. C. hyointestinalis is considered only a rare cause of human enteritis (6, 8, 15) . However, in this study C. hyointestinalis was present in a sample where C. jejuni was assumed to be the sole campylobacter present. A PCR assay from fecal DNA detected C. hyointestinalis although this organism went unrecognized by current culture protocols. This result suggests that fecal DNA PCR could, if applied to large numbers of samples, quantify the proportion of human diarrheic stools containing non-jejuni, non-coli campylobacters. This would clarify the role of campylobacters in human enteric disease.
We were also able to use PCR-RFLP to obtain fla gene fingerprints of the isolates, as well as of campylobacters in the fecal samples. In each case the fecal sample and the isolate had the same genotype (shared the same fingerprint), and two of those corresponded to previously described C. coli fingerprints (20) . The approach of direct genotyping of fecal and environmental material would allow rapid investigation of outbreaks and assist other epidemiological studies. The feasibility of PCR-based typing of C. jejuni in stools was recently demonstrated by using a commercial extraction procedure which is now unavailable (25) , and the authors of this report remarked on the need for a rapid fecal DNA extraction protocol to facilitate routine PCR detection of C. jejuni in stools. The results provided in the present study show that PCR-based detection, identification to the species level, and typing of campylobacters directly from fecal samples are indeed possible for clinical laboratories.
